The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke.

Saved in:
Bibliographic Details
Title: The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke.
Authors: Deiman B; Catharina Hospital Eindhoven, Department of Clinical Chemistry, Eindhoven, the Netherlands. birgit.deiman@catharinaziekenhuis.nl., Hermans M; Catharina Hospital Eindhoven, Department of Clinical Chemistry, Eindhoven, the Netherlands., de Rijk M; Catharina Hospital Eindhoven, Department of Neurology, Eindhoven, the Netherlands., Bras A; Catharina Hospital Eindhoven, Department of Clinical Chemistry, Eindhoven, the Netherlands., Scharnhorst V; Catharina Hospital Eindhoven, Department of Clinical Chemistry, Eindhoven, the Netherlands.
Source: The pharmacogenomics journal [Pharmacogenomics J] 2026 Jun 16; Vol. 26 (3). Date of Electronic Publication: 2026 Jun 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Electronic Cited Medium: Internet ISSN: 1473-1150 (Electronic) Linking ISSN: 1470269X NLM ISO Abbreviation: Pharmacogenomics J Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first